Ardent Health (ARDT) Stock Price

Ardent Health Price

NYSE·CLOSED
12.20
​
Market closed

Revenue has compounded at 12.0% per year over the past 10 years to 6.32 B USD. Earnings per share have grown at 28.1% per year over the last 9 years. Ardent Health's net margin stands at 2.1%, down from 3.2% several years earlier. Analysts set a median price target of 13.00 USD, implying 6.6% above the current price. Of 18 analysts, 12 rate the stock a buy — an overall Buy consensus.

Ardent Health stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ardent Health business model & stock analysis

Ardent Health Inc, trading under the ticker ARDT, is a United States-based company operating within the Health Care sector. Headquartered in Brentwood, Tennessee, the firm provides healthcare services across eight mid-sized urban markets in six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The company operates a network comprising 30 acute care hospitals, 146 primary and specialty care clinics, three ambulatory surgery centers, 22 urgent care centers, two freestanding emergency departments, and ten diagnostic imaging centers. It delivers general and specialty services, including internal medicine, surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency care, in both inpatient and ambulatory settings. Ardent Health also offers telehealth services and a consumer-centric platform. The company employs approximately 19,500 people and conducted its initial public offering on July 18, 2024. Its website is https://ardenthealth.com/.

Frequently asked questions about Ardent Health

Analysts currently set an average price target of 13.33 USD for the Ardent Health stock (median: 13.00 USD), implying +9.3 % versus the latest price. The consensus is based on 18 analyst ratings.

18 analysts currently rate the Ardent Health stock: 12 recommend buying, 5 holding and 1 selling. For 2026, analysts expect Ardent Health to generate revenue of 6.46 B USD and earnings per share of 0.97 USD.

Converted at the current exchange rate, the Ardent Health share trades at 10.87 EUR (12.20 USD).

The expected revenue of Ardent Health is 6.46 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Ardent Health is 136.73 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Ardent Health is currently 12.62. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Ardent Health stock.

The price-to-sales ratio (P/S) of Ardent Health is currently 0.27. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Ardent Health stock.

The Eulerpool Quality Score for Ardent Health is 4/10.

The ISIN of Ardent Health is US03980N1072. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Ardent Health is ARDT. The ticker symbol is used to trade Ardent Health shares on the stock exchange.

Fair ValueTerminal
12.44 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
324,325.08 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jul 18, 2024
ISIN
US03980N1072
Cusip
03980N107
Market capitalization
1.75 B USDSmall Cap
52-Week Range
PEG
1.26
P/E ratio
P/Ee 2026
12.78
P/Ee 2027
10.48
P/Ee 2028
9.58
P/S
P/Se
0.27
EV/EBIT
6.56
P/B Ratio
1.04
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.88 %
Last updated Oct 19, 2026, 3:46 PM

Ardent Health Peer Group